BFRI
Biofrontera Inc. Common StockRecent alerts on BFRI
All signals →
News
Biofrontera Q2 Revenue Jumps 15%
14d ago
News
Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin
19d ago
News
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
74d ago
SEC filing
BFRI Reports $17.1M Q4 Rev, $4.6M Op Income, $6.4M Cash, Ameluz PDT FDA sNDA Accepted, Phase 3 AK Success, $3M Xepi Sale
75d ago
SEC filing
BFRI Announces Positive Phase 3 Results for Ameluz® PDT, Achieving 45.6% Complete Clearance Rate, Plans sNDA Submission Q3 2026
113d ago
Scanner
Unusual volume (2.3x average)
119d ago
Get push alerts for BFRI
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS